Sign in

CIK 0001534120

  • Non-accelerated filer
  • Smaller reporting company

Avalo Therapeutics, Inc.

Sign in to watch
Ticker
AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450705648
Phone
+1 410-522-8707
Business address
1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
Former names
Cerecor Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$395,474
in 3 filings, $395K under 10b5-1 plans

Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-06 Chan Mitchell Director Sale 10b5-1 −3,167 $22.88 $72K 3,166
2026-03-28 Chan Mitchell Director Exercise or conversion +3,166 6,333
2026-03-28 Chan Mitchell Director Exercise or conversion · Restricted Stock Units −3,166 3,167
2025-06-17 Chan Mitchell Director Grant or award · Stock Option (Right to Buy) +20,100 20,100
2025-03-28 Chan Mitchell Director Exercise or conversion +3,167 3,167
2025-03-28 Chan Mitchell Director Exercise or conversion · Restricted Stock Units −3,167 6,333
2024-08-13 Chan Mitchell Director Grant or award · Stock Option (Right to Buy) +24,600 24,600
2024-08-13 Chan Mitchell Director Grant or award · Restricted Stock Units +9,500 9,500
2023-12-20 Chan Mitchell Director Grant or award · Stock Option (Right to Buy) +3,334 3,334
2022-06-14 Chan Mitchell Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2021-12-01 Chan Mitchell Director Grant or award · Stock Option (Right to Buy) +80,000 80,000

Page 1 of 1 · 11 trades